OncoImmunology (Dec 2023)

Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8+ T cells towards the center of human lung tumors

  • Demi Brownlie,
  • Andreas von Kries,
  • Giampiero Valenzano,
  • Nicole Wild,
  • Emel Yilmaz,
  • Jesper Säfholm,
  • Mamdoh Al-Ameri,
  • Evren Alici,
  • Hans-Gustaf Ljunggren,
  • Igor Schliemann,
  • Ozan Aricak,
  • Felix Haglund de Flon,
  • Jakob Michaëlsson,
  • Nicole Marquardt

DOI
https://doi.org/10.1080/2162402X.2023.2233402
Journal volume & issue
Vol. 12, no. 1

Abstract

Read online

ABSTRACTLung cancer is a leading cause of cancer-related death worldwide. Despite recent advances in tissue immunology, little is known about the spatial distribution of tissue-resident lymphocyte subsets in lung tumors. Using high-parameter flow cytometry, we identified an accumulation of tissue-resident lymphocytes including tissue-resident NK (trNK) cells and CD8+ tissue-resident memory T (TRM) cells toward the center of human non-small cell lung carcinomas (NSCLC). Chemokine receptor expression patterns indicated different modes of tumor-infiltration and/or residency between trNK cells and CD8+ TRM cells. In contrast to CD8+ TRM cells, trNK cells and ILCs generally expressed low levels of immune checkpoint receptors independent of location in the tumor. Additionally, granzyme expression in trNK cells and CD8+ TRM cells was highest in the tumor center, and intratumoral CD49a+CD16− NK cells were functional and responded stronger to target cell stimulation than their CD49a− counterparts, indicating functional relevance of trNK cells in lung tumors.In summary, the present spatial mapping of lymphocyte subsets in human NSCLC provides novel insights into the composition and functionality of tissue-resident immune cells, suggesting a role for trNK cells and CD8+ TRM cells in lung tumors and their potential relevance for future therapeutic approaches.

Keywords